Abstract
Thirty evaluable patients with advanced carcinoma of the pancreas received treatment with either daily x 5 bolus or continuous infusion x 5 days recombinant γ-interferon. No responses were noted. Major toxicities included fever, hypotension, and flu-like symptoms. γ-Interferon does not appear to be an active single agent for patients with advanced pancreatic cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 584-587 |
Number of pages | 4 |
Journal | Journal of Biological Response Modifiers |
Volume | 9 |
Issue number | 6 |
State | Published - Dec 1990 |
Keywords
- γ-Interferon
- Pancreatic cancer
ASJC Scopus subject areas
- Cancer Research
- Immunology
- Pharmacology